+86-28-82633987
Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃
17.0700
1.9200
1.8900
High
Yes
No
No
No
No
Negative
Cinnamaldehyde (CAS No.: 104-55-2) is the main volatile aromatic component in the Cinnamaldehyde genus. It belongs to the parent structure of cinnamaldehyde compounds, chemically named (E)-3-phenylpropyl-2-enalde. As a natural product, cinnamaldehyde has attracted widespread attention in recent years in pharmacology, food industry, and agriculture due to its unique aromatic aroma and diverse biological activities. It has multiple pharmacological effects including antibacterial, antifungal, hypoglycemic, vasodilator, and sensitizer, and is widely used in flavorings and food preservatives. With in-depth research into the pharmacological mechanisms of natural products, cinnamaldehyde, as a compound with good safety and drug potential, has gradually revealed its molecular targets and mechanisms of action, showing promising applications in anti-infection, metabolic diseases, and cardiovascular diseases.
This paper will systematically review the chemical structure and physicochemical properties of cinnamaldehyde, plant origin and extraction methods, pharmacological activity and mechanism of action, druggability evaluation, and pharmacokinetic characteristics. Combined with the latest research progress, it will explore its clinical application prospects and future directions, providing theoretical reference for pharmacological research of natural products and new drug development.
Cinnamaldehyde has the chemical formula C9H8O, molecular weight 132.16, and is characterized by a phenyl group connected to the acrolein skeleton α, β-unsaturated aldehyde compounds. Its (E)-isomer, trans cinnamaldehyde, is the main form found in nature, characterized by high stability and biological activity. The molecular structure contains a conjugated aromatic ring and α, β-unsaturated aldehyde groups, giving it strong electrophilic properties and reactive reactivity, enabling covalent binding with functional groups such as thiol and amino groups in biomacromolecules.
In terms of physical and chemical properties, cinnamaldehyde appears as a colorless to pale yellow liquid with a distinctive cinnamon aroma. Its LogP value is about 1.92, indicating moderate lipid solubility, which facilitates cell membrane penetration. The polar surface area (TPSA) is 17.07 Ų, and the number of hydrogen bond acceptors is 1, indicating low molecular polarity and easy absorption by organisms. Cinnamaldehyde can cross the blood-brain barrier (BBB) well, suggesting its potential application value in central nervous system diseases. Toxicological evaluation showed that LD50 was about 2220 mg/kg, with low toxicity, no significant hepatotoxicity, cardiotoxicity, or hERG channel inhibition. Ames-induced mutagenic test results were negative, indicating high safety.
Cinnamaldehyde is mainly found in the bark, leaves, and fruits of the cinnamon tree (Cinnamon spp.), with the highest content found in cinnamon bark. The content of natural cinnamaldehyde is greatly influenced by plant species, geographical environment, harvest time, and processing methods. Common cinnamon varieties include Chinese cinnamon (Cinnamomum cassia) and Ceylon cinnamon (Cinnamomum verum).
There are various methods for extracting cinnamaldehyde, mainly including distillation, solvent extraction, and supercritical CO2 extraction. Traditional distillation uses steam distillation to extract volatile fats, followed by fractional distillation to obtain cinnamaldehyde. Solvent extraction commonly uses organic solvents such as ethanol and ether, suitable for extracting non-volatile and partially volatile components. Supercritical CO2 extraction has been widely researched and applied in recent years due to its strong selectivity, solvent-free residue, and environmental friendliness. Improvements in extraction purity and yield lay the foundation for large-scale production and application of cinnamaldehyde.
Cinnamaldehyde exhibits broad-spectrum antibacterial and antifungal activity, inhibiting various Gram-positive bacteria, Gram-negative bacteria, and fungi. Its antibacterial targets involve key enzymes such as bacterial DNA gyrase (GYRA), cell wall synthase (FABI), and dihydrofolate reductase (DHFR), which can interfere with bacterial DNA replication, cell wall synthesis, and metabolic processes. Additionally, cinnamaldehyde inhibits fungal ERG11(CYP51A1) enzymes, blocking the synthesis of sterol in fungal cell membranes and exerting antifungal effects. Its antibacterial mechanisms include damaging cell membrane integrity, inhibiting enzyme activity, and inducing oxidative stress, indicating a low risk of resistance.
Cinnamaldehyde shows significant activity in regulating glucose metabolism, improving insulin sensitivity, promoting glucose uptake, and lowering blood sugar levels. Its mechanism of action is partly attributed to inhibition of p-phenylalanine aminolytic enzyme (EC 4.3.1.24), which affects amino acid metabolism and gluconeogenesis. Additionally, cinnamaldehyde can activate the AMPK signaling pathway, regulate lipid metabolism, and reduce insulin resistance, showing potential for treating type 2 diabetes and metabolic syndrome.
Cinnamaldehyde has vasodilatory effects, promoting NO production, reducing vascular tone, and improving hemodynamics by regulating endothelial nitric oxide synthase (eNOS) activity. Its antioxidant and anti-inflammatory properties help reduce vascular endothelial damage and prevent atherosclerosis and hypertension-related cardiovascular diseases. Animal experiments have shown that cinnamaldehyde can lower blood pressure, improve myocardial ischemia-reperfusion injury, and has good cardiovascular protective effects.
Cinnamaldehyde can inhibit various pro-inflammatory factors such as TNF-α, IL-6, and NF-κB signaling pathways, reducing inflammatory responses. Its antioxidant activity mainly works by scavenging free radicals and enhancing endogenous antioxidant enzyme activity (such as SOD, CAT), protecting cells from oxidative damage. This property gives cinnamaldehyde potential value in the prevention and treatment of chronic inflammatory diseases and neurodegenerative diseases.
Cinnamaldehyde also exhibits sensitizing effects, which can enhance the effectiveness of certain medications or treatments. Moreover, as a seasoning, it is widely used in the food industry, combining safety and functionality.
The multi-target mechanism of cinnamaldehyde forms the basis for its various pharmacological effects. Key targets include:
Bacterial targets: GYRA (DNA gyrase A), FABI (fatty acid synthase), DHFR (dihydrofolate reductase), FTSZ (cell division protein), MECA (cell membrane protein), PENA (penicillin-binding protein), CDR1 (fungal multidrug resistance protein), etc. Cinnamaldehyde blocks the growth and reproduction of bacteria and fungi by inhibiting the activity of these enzymes.
Metabolic enzymes: Phenylalanine ammonia-lying enzyme (EC 4.3.1.24) is a target of cinnamaldehyde that regulates amino acid and glucose metabolism, affecting gluconeogenesis and energy metabolism.
Signaling Pathways: The regulation of signaling pathways such as AMPK, NF-κB, and eNOS forms the molecular basis for their hypoglycemic, anti-inflammatory, and vasodilatory effects.
Oxidative stress-related targets: cinnamaldehyde regulates the Nrf2/ARE pathway, enhances antioxidant enzyme expression, and reduces oxidative damage.
Additionally, cinnamaldehyde's α β-unsaturated aldehyde group structure allows it to form covalent addition with protein thiol groups, regulating protein function and further enriching its mechanism of action.
Druggability evaluation of cinnamaldehyde indicates it has promising potential for drug development. It has moderate molecular weight, moderate lipid solubility, low polarity, and is easy to absorb orally. Its high blood-brain barrier penetration capability suggests its potential for treating diseases related to the central nervous system. Toxicological data indicate that cinnamaldehyde is relatively safe, with no significant hepatotoxicity, cardiotoxicity, or mutagenicity, making it suitable for long-term use.
Pharmacokinetic studies show that cinnamaldehyde is rapidly absorbed orally and widely distributed, mainly metabolized by the liver, with cinnamic acid and its conjugates as the main metabolites. It has a moderate half-life and good clearance rates in the body. Due to its volatility and chemical activity, improving formulation stability and bioavailability is a key focus for future research.
As a versatile natural product, cinnamaldehyde shows broad prospects for clinical applications. Its antibacterial and antifungal effects provide new ideas for anti-infective drug development, especially in the context of increasingly prevalent antibiotic-resistant bacteria. Its hypoglycemic and metabolic regulation effects make it a potential candidate for adjunctive treatment of diabetes and metabolic syndrome. Vasodilation and cardiovascular protection provide a natural drug option for the prevention and treatment of cardiovascular diseases.
In the future, structural optimization based on cinnamaldehyde and the application of drug carrier technology are expected to improve its bioavailability and targeting, expanding its clinical indications. In addition, in-depth analysis of its molecular mechanisms and safety evaluation will provide a solid foundation for its clinical translation. By combining modern medicinal chemistry, molecular biology, and pharmacological technologies, cinnamaldehyde is expected to become an important model for natural product drug development.
Cinnamaldehyde, as a natural product with a wide origin, simple structure, and rich bioactivity, demonstrates excellent druggability and clinical application potential due to its multi-target and multi-mechanism pharmacological properties. Its research in antibacterial, hypoglycemic, vasodilation, and anti-inflammatory fields has been continuously deepening, driving the development of natural product pharmacology. In the future, through systematic pharmacokinetic research, structural optimization, and clinical trial validation, cinnamaldehyde is expected to become a safe and effective natural medicine, contributing new strength to human health.
Shenshuai
Wenjing
Hedandan
